P9020, Platelet rich plasma, each unit
HCPCS/CPT
Prior Authorization
No Prior Auth Required
Code is covered without prior authorization (high confidence)
Medicare Pricing
Documentation Required
- This billing and coding guidance complements Local Coverage Determination (LCD) L38745 for Platelet Rich Plasma; refer to LCD L38745 for specific clinical indications, coverage rules, and required documentation.
- This article contains billing, coding, or guideline information that complements the LCD; specific documentation, prior authorization, or forms are not specified here and must be obtained from the LCD or payer.
- Billing, coding, and supporting documentation requirements are provided as a complement to LCD L39023; claims must include the documentation required by LCD L39023.
- Follow the Local Coverage Determination L39058 and CMS NCD 270.3 for clinical indications and supporting documentation to justify PRP use and appropriate code selection.
- When billing P9020, document the number of PRP units transfused (bill one or more P9020 units equal to units transfused); when billing 0232T, document that a kit was used to prepare PRP and that the service is an injection.
- The submitted medical record must support the use of the selected ICD-10-CM code(s).
Key Coverage Criteria
- This article does not list specific covered indications; coverage is determined by the referenced Local Coverage Determination (LCD) for Platelet Rich Plasma.
- Refer to Local Coverage Determination L39023 for covered indications for platelet-rich plasma (PRP) injections for non-wound indications.
- Platelet-rich plasma (PRP) used for treatment of chronic non-healing wounds is covered when it meets CMS National Coverage Determination (NCD) 270.3; bill using HCPCS G0460/G0465 accordingly.
- HCPCS P9020 should be billed for one or more units of PRP transfused when used to treat conditions or coagulopathies for which PRP transfusion is indicated.
- Platelet-rich plasma (PRP) is covered only when the service meets the reasonable and necessary requirements specified in Local Coverage Determination (LCD) L39068.
- When billing for G0465 (blood-derived products for chronic non-healing wounds), coverage follows National Coverage Determination (NCD) 270.3 and must meet that NCD's criteria.
20 Active Policies
CGS-L39023, Platelet Rich Plasma Injections for Non-Wound Injections
J15
A58609, Billing and Coding: Platelet Rich Plasma
J6
A58810, Billing and Coding: Platelet Rich Plasma
J9
FIRST_COAST-L39071, Platelet Rich Plasma
J9
NORIDIAN-L39058, Platelet Rich Plasma Injections for Non-Wound Injections
JF
NOVITAS-L39068, Platelet Rich Plasma
JH
PALMETTO-JJ-L38745, Platelet Rich Plasma
JJ
NGS-L38937, Platelet Rich Plasma
JK
A58808, Billing and Coding: Platelet Rich Plasma
JL
PALMETTO-JM-L38745, Platelet Rich Plasma
JM
AETNA-CPB-0602, Intradiscal Procedures
AETNA-CPB-0244, Skin and Soft Tissue Substitutes
UMR-POL-UMR-prolotherapy-platelet-rich-plasma-therapies, Prolotherapy and Platelet Rich Plasma Therapies
SUREST-POL-SUREST-prolotherapy-platelet-rich-plasma-therapies, Prolotherapy and Platelet Rich Plasma Therapies
UHCMA-POL-UHC_MA-platelet-rich-plasma-therapies, Platelet Rich Plasma Therapies
AETNA-CPB-0235, Plantar Fasciitis Treatments
A58282, Billing and Coding: Platelet Rich Plasma
A58737, Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
A58788, Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
UHC-POL-prolotherapy-platelet-rich-plasma-therapies, Prolotherapy and Platelet Rich Plasma Therapies
Related Codes
Have a follow-up question?
Ask Verity about documentation requirements, denial risks, or coverage in your state.